Zoom has completed its third strategic investment in video meeting technology maker Neat, which is now valued at $640m.
Month: September 2021
TrueFort locks up $30m
Ericsson Ventures has participated in a series B round for cybersecurity software provider TrueFort, reportedly increasing its total funding to almost $48m.
Eventus enters $30m series B round
The Coinbase Ventures-backed fraud prevention tool developer has secured the fresh round that boosted its total funding to over $48m.
Daily Deal Round Up: September 9, 2021
Stratasys spinoff Evolve Additive Solutions secured $30m from 3D Ventures while CollegeDekho – spun off by GirnarSoft – raised $26.5m.
Powerlist Q&A – Bill Taranto, Merck GHI Fund
Q&A with William Taranto, president, Merck Global Health Innovation (GHI) Fund, and vice-president, Merck Global Health Innovation Group
Volkswagen races to launch corporate venturing fund
The carmaker intends to allocate $356m to the vehicle, which will invest in early-stage companies in addition to decarbonisation schemes.
Energy Vault locks in $1.1bn reverse merger
SoftBank Vision Fund and SAEV – both existing investors in the enrgy storage technology developer – contributed to a $100m PIPE financing supporting the deal.
Aviatrix accesses $200m series E
Networking and cybersecurity technology provider Aviatrix was valued at $2bn through a series E round backed by existing investor Liberty Global Ventures.
Addi lifts series B round to $140m
The online lender, which is backed by Telefónica’s Wayra unit, has completed a $75m close, tripling its valuation to the nine-digit dollar range.
Procept plots $132m IPO
Novo-backed surgical robot maker Procept will fund recruitment and product development initiatives with the proceeds of an IPO for which it has just set terms.
InBrace wires shut $102m series D
Existing backer Novo has helped the teeth straightening technology producer close a series D round hiking its overall funding to over $170m.
SingleStore takes in $80m
Dell, Hewlett Packard, Relx and Alphabet helped boost the database technology provider’s total funding to $264m.
Adarx advances to series B with $75m
SR One Capital Management has led the RNA targeting drug developer’s latest round, participating alongside investors including Lilly Asia Ventures.
Owlstone breathes in $58m
The Aviva and Foxconn-backed respiratory system developer beat the target for its series D round to bring its total funding to over $150m.